Zytiga and Pancytopenia - a phase IV clinical study of FDA data

Summary:

Pancytopenia is reported as a side effect among people who take Zytiga (abiraterone acetate), especially for people who are male, 60+ old, have been taking the drug for 1 - 6 months also take Prednisone, and have Prostate cancer.

The phase IV clinical study analyzes which people have Pancytopenia when taking Zytiga. It is created by eHealthMe based on reports of 29,870 people who have side effects when taking Zytiga from the FDA, and is updated regularly.

What is Zytiga?

Zytiga has active ingredients of abiraterone acetate. It is often used in prostate cancer metastatic. eHealthMe is studying from 29,928 Zytiga users. Check the latest studies of Zytiga.

What is Pancytopenia?

Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets) is found to be associated with 1,791 drugs and 2,432 conditions by eHealthMe. Check the latest studies of Pancytopenia.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 28, 2026

29,870 people reported to have side effects when taking Zytiga.
Among them, 55 people (0.18%) have Pancytopenia.

Among these 55 people:

How long have people been on Zytiga when they have Pancytopenia? *

What is the gender of people who have Pancytopenia when taking Zytiga? *

female: 3.7 %
male: 96.3 %

What is the age of people who have Pancytopenia when taking Zytiga? *

What are other drugs people take besides Zytiga? *

What are other side effects people have besides Pancytopenia? *

Anaemia (lack of blood): 14 people, 25.45%
Thrombocytopenia (decrease of platelets in blood): 10 people, 18.18%
Weakness: 6 people, 10.91%
Haematuria (presence of blood in urine): 6 people, 10.91%
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 6 people, 10.91%
Fatigue (feeling of tiredness): 6 people, 10.91%
Nausea (feeling of having an urge to vomit): 5 people, 9.09%
General Physical Health Deterioration (weak health status): 5 people, 9.09%
Metastases To Bone (cancer spreads to bone): 5 people, 9.09%
Malignant Neoplasm Progression (cancer tumour came back): 5 people, 9.09%

What are the existing conditions these people have? *

Prostate Cancer: 18 people, 32.73%
Metastases To Bone (cancer spreads to bone): 9 people, 16.36%
Enlarged Prostate: 5 people, 9.09%
Prostate Cancer Stage Iv: 4 people, 7.27%
High Blood Pressure: 4 people, 7.27%
Hypokalemia (low potassium): 3 people, 5.45%
Gastric Ulcer (stomach ulcer): 3 people, 5.45%
Hepatic Cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue): 3 people, 5.45%
Pain: 3 people, 5.45%
Adenocarcinoma (malignant tumour formed from glandular structures in epithelial tissue): 3 people, 5.45%

* Approximation only. Some reports may have incomplete information.

Do you take Zytiga and have Pancytopenia?

- Check whether Pancytopenia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Zytiga:

Zytiga (29,928 reports)

Pancytopenia treatments and more:

Pancytopenia (69,290 reports)

Browse all side effects of Zytiga:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Pancytopenia:

Pancytopenia (1,791 drugs)

Browse all the conditions that are associated with Pancytopenia:

Pancytopenia (2,432 conditions)

Related publications that referenced our studies

Ate? ?, Arikan MF, Kaplan M, Altay M, "Hydroxyzine induced pancytopenia and petechial rashes: a rare complication", Journal Of Contemporary Medicine, 2017 Jan .
Erden M, Gulcan E, Bilen A, Bilen Y, Uyanik A, Keles M, "Pancytopen? a and Seps? s due to Meropenem: A Case Report", Tropical Journal of Pharmaceutical Research, 2013 Jan .
Ate? ?, Arikan MF, Kaplan M, Altay M, "Hydroxyzine induced pancytopenia and petechial rashes: a rare complication", Journal Of Contemporary Medicine, 2017 Jan .
Erden M, Gulcan E, Bilen A, Bilen Y, Uyanik A, Keles M, "Pancytopen? a and Seps? s due to Meropenem: A Case Report", Tropical Journal of Pharmaceutical Research, 2013 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on abiraterone acetate (the active ingredients of Zytiga) and Zytiga (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.